ClearPoint Neuro (CLPT) Profit After Tax Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -19.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.42% |
| Dec 31, 2025 | -21.09% |
| Sep 30, 2025 | -15.86% |
| Jun 30, 2025 | -10.70% |
| Mar 31, 2025 | -15.03% |
| Dec 31, 2024 | -9.09% |
| Sep 30, 2024 | -7.71% |
| Jun 30, 2024 | -5.60% |
| Mar 31, 2024 | -17.77% |
| Dec 31, 2023 | -42.93% |
| Sep 30, 2023 | -47.98% |
| Jun 30, 2023 | -61.93% |
| Mar 31, 2023 | -39.75% |
| Dec 31, 2022 | -38.63% |
| Sep 30, 2022 | -49.97% |
| Jun 30, 2022 | -40.53% |
| Mar 31, 2022 | -48.02% |
| Dec 31, 2021 | -50.47% |
| Sep 30, 2021 | -40.73% |
| Jun 30, 2021 | -25.88% |
| Mar 31, 2021 | -15.65% |
| Sep 30, 2019 | 24.05% |
| Jun 30, 2019 | 4.53% |
| Mar 31, 2019 | 15.78% |
| Sep 30, 2018 | -79.87% |
| Jun 30, 2018 | 15.04% |
| Mar 31, 2018 | 25.35% |
| Sep 30, 2016 | 7.08% |
| Jun 30, 2016 | -9.64% |
| Mar 31, 2016 | -35.38% |
| Sep 30, 2015 | 55.37% |
| Jun 30, 2015 | -72.13% |
| Mar 31, 2015 | -4.33% |
| Dec 31, 2014 | -1.05% |
| Sep 30, 2014 | -19.53% |
| Jun 30, 2014 | 8.35% |
| Mar 31, 2014 | 46.88% |